Since obesity is a main risk factor for type 2 diabetes, hyperaldosteronism in obese patients can contribute to a change in glucose tolerance both by affecting insulin secretion and by changing insulin sensitivity [103]. The gene discussed is INS; the disease is type 2 diabetes mellitus.